Advertisement

Optimization of Anti-CXCL10 Nanobody Expression Using Response Surface Methodology and Evaluation of its Anti-metastatic Effect on Breast Cancer cells

  • Tahereh Sadeghian-Rizi
  • Mahdi Behdani
  • Fateme Naghavi-al-hosseini
  • Seyedeh Simin Dakhilpour
  • Hossein Khanahmad
  • Ali Jahanian-NajafabadiEmail author
Article
  • 4 Downloads

Abstract

Some chemokines and chemokine receptors play important roles in various types of autoimmune diseases, infectious diseases and cancer metastasis. Hence, production of neutralizing antibodies against them are under active investigation. We previously developed a nanobody against CXCL10, designated as 3NB12, which can be expressed by E. coli cells. In the present study, we carried out a detailed study to optimize its expression using response surface methodology based on manipulation of three variables, including temperature, IPTG concentration, and post-induction time. In addition, upon expression and purification of the nanobody, it was also used to evaluate its inhibitory effects on migration of CXCR3 overexpressing MDA-MB-231 breast cancer cells. Seventeen experiments were designed. Total protein of the designed experiments was assayed by SDS-PAGE, followed by size exclusion chromatography to qualify and quantify the relative concentration of the nanobody in the optimized expression condition. The model designed according to the Box Behnken method predicted maximum 3NB12 expression at 28.5 °C, a post-induction time length of 15 h, and 0.9 mM IPTG. Chemotaxic assessment results showed that 3NB12 potently inhibits migration of the cells which has an important role in methastasis of breast cancer. Taken together, a reasonable amount of the nanobody could be produced according to the present study for being used in later in vitro and in vivo studies to further evaluate its anti metastatic and also anti-inflamatory effects.

Keywords

Nanobody Chemokine CXCL10 CXCR3 Optimization of expression Response surface methodology 

Notes

Acknowledgements

The content of this paper is extracted from the Ph.D thesis NO. 394942 and research project NO. 195151 which was financially supported by the Research Department of Isfahan University of Medical Sciences, Isfahan, I.R. Iran.

Funding

The content of this paper is extracted from the Ph.D thesis NO. 394942 and research project NO. 195151 which was financially supported by the Research Department of Isfahan University of Medical Sciences, Isfahan, I.R. Iran.

Compliance with Ethical Standards

Conflict of interest

Tahereh Sadeghian-Rizi, Mahdi Behdani, Fateme Naghavi-al-hosseini, Seyedeh Simin Dakhilpour, Hossein Khanahmad, and Ali Jahanian-Najafabadi declare that they have no conflict of interest.

Ethical Approval

This article does not contain any studies with human participants or animals performed by any of the authors.

References

  1. Ahmed M, Basheer HA, Ayuso JM, Ahmet D, Mazzini M, Patel R, Shnyder SD, Vinader V, Afarinkia K (2017) Agarose spot as a comparative method for in situ analysis of simultaneous chemotactic responses to multiple chemokines. Sci Rep 7(1):1075PubMedPubMedCentralCrossRefGoogle Scholar
  2. Akbari V, Sadeghi HM, Jafarian-Dehkordi A, Chou CP, Abedi D (2015) Optimization of a single-chain antibody fragment overexpression in Escherichia coli using response surface methodology. RPS 10(1):75–83PubMedGoogle Scholar
  3. Arbabi-Ghahroudi M (2017) Camelid single-domain antibodies: historical perspective and future outlook. Front Immunol 8:1589PubMedPubMedCentralCrossRefGoogle Scholar
  4. Bai M, Chen X, Ba YI (2016) CXCL10/CXCR3 overexpression as a biomarker of poor prognosis in patients with stage II colorectal cancer. Mol Clin Oncol 4(1):23–30PubMedCrossRefGoogle Scholar
  5. Blanchetot C, Verzijl D, Mujić-Delić A, Bosch L, Rem L, Leurs R, Verrips CT, Saunders M, Haard HD, Smit MJ (2013) Neutralizing nanobodies targeting diverse chemokines effectively inhibit chemokine function. J Biol Chem 288(35):25173–25182PubMedPubMedCentralCrossRefGoogle Scholar
  6. Box GEP, Behnken DW (1960) Some new three level designs for the study of quantitative variables. Technometrics 2(4):455–475CrossRefGoogle Scholar
  7. Cao W, Li H, Zhang J, Li D, Acheampong DO, Chen Z, Wang M (2013) Periplasmic expression optimization of VEGFR2 D3 adopting response surface methodology: antiangiogenic activity study. Protein Exp Purif 90(2):55–66PubMedCrossRefGoogle Scholar
  8. Chaturvedi P, Gilkes DM, Wong CC, Luo W, Zhang H, Wei H, Takano N, Schito L, Levchenko A, Semenza GL (2013) Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis. J Clin Invest 123(1):189–205PubMedGoogle Scholar
  9. Conrath KE, Lauwereys M, Galleni M, Matagne A, Frère J-M, Kinne J, Wyns L, Muyldermans S (2001) β-Lactamase inhibitors derived from single-domain antibody fragments elicited in the camelidae. Antimicrob Agents Chemother 45(10):2807PubMedPubMedCentralCrossRefGoogle Scholar
  10. de Marco A (2015) Recombinant antibody production evolves into multiple options aimed at yielding reagents suitable for application-specific needs. Microb Cell Fact 14:125PubMedPubMedCentralCrossRefGoogle Scholar
  11. Diaz-Dinamarca DA, Jerias JI, Soto DA, Soto JA, Diaz NV, Leyton YY, Villegas RA, Kalergis AM, Vásquez AE (2018) The optimisation of the expression of recombinant surface immunogenic protein of group B Streptococcus in Escherichia coli by response surface methodology improves humoral immunity. Mol Biotechnol 60(3):215–225PubMedCrossRefGoogle Scholar
  12. Farasat A, Rahbarizadeh F, Ahmadvand D, Yazdian F (2017) Optimization of an anti-HER2 nanobody expression using the Taguchi method. Prep Biochem Biotechnol 47(8):795–803PubMedCrossRefGoogle Scholar
  13. Ferreira SL, Bruns RE, Ferreira HS, Matos GD, David JM, Brandao GC, da Silva EG, Portugal LA, dos Reis PS, Souza AS, dos Santos WN (2007) Box-Behnken design: an alternative for the optimization of analytical methods. Anal Chim Acta 597(2):179–186PubMedCrossRefGoogle Scholar
  14. Ghaderi H, Arasteh J, Hesampour A (2018) Using response surface methodology in combination with Plackett-Burman design for optimization of culture media and extracellular expression of Trichoderma reesei synthetic endoglucanase II in Escherichia coli. Mol Biol Rep 45(5):1197–1208PubMedCrossRefGoogle Scholar
  15. Girard SD, Virard I, Lacassagne E, Paumier JM, Lahlou H, Jabes F, Molino Y, Stephan D, Baranger K, Belghazi M, Deveze A, Khrestchatisky M, Nivet E, Roman FS, Féron F (2017) From blood to lesioned brain: an in vitro study on migration mechanisms of human nasal olfactory stem cells. Stem Cells Int 2017:1478606PubMedPubMedCentralCrossRefGoogle Scholar
  16. Griffith JW, Sokol CL, Luster AD (2014) Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev Immunol 32:659–702PubMedCrossRefGoogle Scholar
  17. Guyon A, Kussrow A, Olmsted IR, Sandoz G, Bornhop DJ, Nahon J-L (2013) Baclofen and other GABAB receptor agents are allosteric modulators of the CXCL12 chemokine receptor CXCR4. J Neurosci 33(28):11643PubMedPubMedCentralCrossRefGoogle Scholar
  18. Hassanzadeh-Ghassabeh G, Devoogdt N, De Pauw P, Vincke C, Muyldermans S (2013) Nanobodies and their potential applications. Nanomedicine 8(6):1013–1026PubMedCrossRefGoogle Scholar
  19. Iqbal MK, Nadeem A, Sherazi F, Khan RA (2015) Optimization of process parameters for kitchen waste composting by response surface methodology. Int J Environ Sci Technol 12(5):1759–1768CrossRefGoogle Scholar
  20. Jin T, Xu X, Hereld D (2008) Chemotaxis, chemokine receptors and human disease. Cytokine 44(1):1–8PubMedPubMedCentralCrossRefGoogle Scholar
  21. Khalilzadeh R, Shojaosadati SA, Bahrami A, Maghsoudi N (2003) Over-expression of recombinant human interferon-gamma in high cell density fermentation of Escherichia coli. Biotechnol Lett 25(23):1989–1992PubMedCrossRefGoogle Scholar
  22. Kim N, Yoon Y-I, Yoo HJ, Tak E, Ahn C-S, Song G-W, Lee SG, Hwang S (2016) Combined detection of serum IL-10, IL-17, and CXCL10 predicts acute rejection following adult liver transplantation. Mol Cells 39(8):639–644PubMedPubMedCentralCrossRefGoogle Scholar
  23. Ko H-K, Guo L-w, Su B, Gao L, Gelman IH (2014) Suppression of chemotaxis by SSeCKS via scaffolding of phosphoinositol phosphates and the recruitment of the Cdc42 GEF, Frabin, to the leading edge. PLoS ONE 9(10):e111534PubMedPubMedCentralCrossRefGoogle Scholar
  24. Larentis AL, Nicolau JFMQ, Esteves GDS, Vareschini DT, de Almeida FVR, dos Reis MG, Galler R, Medeiros MA (2014) Evaluation of pre-induction temperature, cell growth at induction and IPTG concentration on the expression of a leptospiral protein in E. coli using shaking flasks and microbioreactor. BMC Res Notes 7:671PubMedPubMedCentralCrossRefGoogle Scholar
  25. Liu M, Guo S, Stiles JK (2011) The emerging role of CXCL10 in cancer. Oncol Lett 2(4):583–589PubMedPubMedCentralCrossRefGoogle Scholar
  26. Magee KE, Kelsey CE, Kurzinski KL, Ho J, Mlakar LR, Feghali-Bostwick CA, Torok KS (2013) Interferon-gamma inducible protein-10 as a potential biomarker in localized scleroderma. Arthritis Res Ther 15(6):R188PubMedPubMedCentralCrossRefGoogle Scholar
  27. Maharjan S, Singh B, Bok JD, Kim JI, Jiang T, Cho CS, Kang SK, Choi YJ (2014) Exploring codon optimization and response surface methodology to express biologically active transmembrane RANKL in E. coli. PLoS ONE 9(5):e96259PubMedPubMedCentralCrossRefGoogle Scholar
  28. Matsushima K, Terashima Y, Toda E, Shand F, Ueha S (2011) Chemokines in inflammatory and immune diseases. Inflamm Regen 31(1):11–22CrossRefGoogle Scholar
  29. Mohajeri A, Abdolalizadeh J, Pilehvar-Soltanahmadi Y, Kiafar F, Zarghami N (2016) Expression and secretion of endostar protein by Escherichia Coli: optimization of culture conditions using the response surface methodology. Mol Biotechnol 58(10):634–647PubMedCrossRefGoogle Scholar
  30. Murdoch C, Finn A (2000) Chemokine receptors and their role in inflammation and infectious diseases. Blood 95(10):3032–3043PubMedGoogle Scholar
  31. Nourshargh S, Alon R (2014) Leukocyte migration into inflamed tissues. Immunity 41(5):694–707PubMedCrossRefGoogle Scholar
  32. Papaneophytou CP, Kontopidis G (2014) Statistical approaches to maximize recombinant protein expression in Escherichia coli: a general review. Protein Expr Purif 94:22–32PubMedCrossRefGoogle Scholar
  33. Qiu X, Wegner KD, Wu Y-T, van Bergen en Henegouwen PMP, Jennings TL, Hildebrandt N (2016) Nanobodies and antibodies for duplexed EGFR/HER2 immunoassays using terbium-to-quantum dot fret. Chem Mater 28(22):8256–8267CrossRefGoogle Scholar
  34. Sadeghian-Rizi T, Behdani Khanahmad H, Ghasemi-Dehkordi P, Sadeghi HM, Jahanian-Najafabadi A (2018a) Production of novel camelid anti-cxcl10 specific polyclonal antibodies and evaluation of their bioreactivity. Int J Pept Res Ther 2018:1–6.  https://doi.org/10.1007/s10989-018-9697-6 CrossRefGoogle Scholar
  35. Sadeghian-Rizi T, Khanahmad H, Jahanian-Najafabadi A (2018b) Therapeutic targeting of chemokines and chemokine receptors in multiple sclerosis: opportunities and challenges. CNS Neurol Disord Drug Targets 17(7):496–508PubMedCrossRefGoogle Scholar
  36. Sadeghian-Rizi T, Behdani M, Khanahmad H, Sadeghi HM, Jahanian-Najafabadi A (2019) Generation and characterization of a functional Nanobody against inflammatory chemokine CXCL10, as a novel strategy for treatment of multiple sclerosis. CNS Neurol Disord Drug Targets 18(2):141–148PubMedCrossRefGoogle Scholar
  37. Schumacher D, Helma J, Schneider AFL, Leonhardt H, Hackenberger CPR (2018) Nanobodies: chemical functionalization strategies and intracellular applications. Angew Chem Int Ed Engl 57(9):2314–2333PubMedPubMedCentralCrossRefGoogle Scholar
  38. Siontorou CG (2013) Nanobodies as novel agents for disease diagnosis and therapy. Int J Nanomed 8:4215–4227CrossRefGoogle Scholar
  39. Stalhammar ME, Douhan Hakansson L, Jonzon A, Sindelar R (2017) Differential neutrophil chemotactic response towards IL-8 and bacterial N-formyl peptides in term newborn infants. Ups J Med Sci 122(1):35–42PubMedCrossRefGoogle Scholar
  40. Thomassen YE, Verkleij AJ, Boonstra J, Verrips CT (2005) Specific production rate of VHH antibody fragments by Saccharomyces cerevisiae is correlated with growth rate, independent of nutrient limitation. J Biotechnol 118(3):270–277PubMedCrossRefGoogle Scholar
  41. Trinker MU, Kungl AJ (2012) Targeting chemokine-glycan interactions: the Cell Jammer® technology platform. Drug Discov Today Technol 9(4):e227–314CrossRefGoogle Scholar
  42. Van Audenhove I, Gettemans J (2016) Nanobodies as versatile tools to understand, diagnose, visualize and treat cancer. eBioMedicine 8:40–48PubMedPubMedCentralCrossRefGoogle Scholar
  43. Vinader V, Al-Saraireh Y, Wiggins HL, Rappoport JZ, Shnyder SD, Patterson LH, Afarinkia K (2011) An agarose spot chemotaxis assay for chemokine receptor antagonists. J Pharmacol Toxicol Methods 64(3):213–216PubMedCrossRefGoogle Scholar
  44. Xie L, Hall D, Eiteman MA, Altman E (2003) Optimization of recombinant aminolevulinate synthase production in Escherichia coli using factorial design. Appl Microbiol Biotechnol 63(3):267–273PubMedCrossRefGoogle Scholar
  45. Xie H-Y, Shao Z-M, Li D-Q (2017) Tumor microenvironment: driving forces and potential therapeutic targets for breast cancer metastasis. Chin J Cancer 36(1):36.  https://doi.org/10.1186/s40880-017-0202-y PubMedPubMedCentralCrossRefGoogle Scholar
  46. Zarei M, Nezafat N, Morowvat MH, Dehshahri A, Ghoshoon MB, Berenjian A, Ghasemi Y (2017) Medium optimization for recombinant soluble arginine deiminase expression in Escherichia coli using response surface methodology. Curr Pharm Biotechnol 18(11):935–941PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature B.V. 2019

Authors and Affiliations

  • Tahereh Sadeghian-Rizi
    • 1
  • Mahdi Behdani
    • 2
  • Fateme Naghavi-al-hosseini
    • 3
  • Seyedeh Simin Dakhilpour
    • 4
  • Hossein Khanahmad
    • 5
  • Ali Jahanian-Najafabadi
    • 1
    Email author
  1. 1.Department of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical SciencesIsfahan University of Medical SciencesIsfahanIran
  2. 2.Biotechnology Research Center, Medical Biotechnology Research Center, Pasteur Institute of IranTehranIran
  3. 3.Student Research Committee, School of Pharmacy and Pharmaceutical SciencesIsfahan University of Medical SciencesIsfahanIran
  4. 4.Traditional Medicine and Medicinal PlantsIranian Academy Center for Education, Culture and Research (ACECR), Medicinal Herbal Center, Ardabil BranchArdabilIran
  5. 5.Department of Genetics and Molecular BiologyIsfahan University of Medical ScienceIsfahanIran

Personalised recommendations